Sandra M. Schmucker-Mueller

Erlangen, BY 91054, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Development and characterization of a human papillomavirus-based nanoparticle carrier for heterologous vaccine antigens.

Development and characterization of a human papillomavirus-based nanoparticle carrier for heterologous vaccine antigens.

Journal: Scientific reports
Published: March 10, 2025

Influence of AAV vector tropism on long-term expression and Fc-γ receptor binding of an antibody targeting SARS-CoV-2.

Influence of AAV vector tropism on long-term expression and Fc-γ receptor binding of an antibody targeting SARS-CoV-2.

Journal: Communications biology
Published: November 17, 2023

Modulation of immune responses to liposomal vaccines by intrastructural help.

Modulation of immune responses to liposomal vaccines by intrastructural help.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: July 31, 2023

Clinical and immunological benefits of full primary COVID-19 vaccination in individuals with SARS-CoV-2 breakthrough infections: A prospective cohort study in non-hospitalized adults.

Clinical and immunological benefits of full primary COVID-19 vaccination in individuals with SARS-CoV-2 breakthrough infections: A prospective cohort study in non-hospitalized adults.

Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Published: July 19, 2023

Characterization of SARS-CoV-2 Escape Mutants to a Pair of Neutralizing Antibodies Targeting the RBD and the NTD.

Characterization of SARS-CoV-2 Escape Mutants to a Pair of Neutralizing Antibodies Targeting the RBD and the NTD.

Journal: International journal of molecular sciences
Published: June 24, 2022

Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization.

Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization.

Journal: Nature communications
Published: July 30, 2021

A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model.

A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model.

Journal: European journal of immunology
Published: May 17, 2021

T-cell receptor transfer for boosting HIV-1-specific T-cell immunity in HIV-1-infected patients.

T-cell receptor transfer for boosting HIV-1-specific T-cell immunity in HIV-1-infected patients.

Journal: AIDS (London, England)
Published: June 04, 2016

Cross-Reactivity Between Influenza Matrix- and HIV-1 P17-Specific CTL-A Large Cohort Study.

Cross-Reactivity Between Influenza Matrix- and HIV-1 P17-Specific CTL-A Large Cohort Study.

Journal: Journal of acquired immune deficiency syndromes (1999)
Published: April 23, 2015

Identification of HLA-C restricted, HIV-1-specific CTL epitopes by peptide induced upregulation of HLA-C expression.

Identification of HLA-C restricted, HIV-1-specific CTL epitopes by peptide induced upregulation of HLA-C expression.

Journal: Journal of immunological methods
Published: October 28, 2014

T cell costimulation molecules CD80/86 inhibit osteoclast differentiation by inducing the IDO/tryptophan pathway.

T cell costimulation molecules CD80/86 inhibit osteoclast differentiation by inducing the IDO/tryptophan pathway.

Journal: Science translational medicine
Published: May 09, 2014

HIV-1 mRNA electroporation of PBMC: a simple and efficient method to monitor T-cell responses against autologous HIV-1 in HIV-1-infected patients.

HIV-1 mRNA electroporation of PBMC: a simple and efficient method to monitor T-cell responses against autologous HIV-1 in HIV-1-infected patients.

Journal: Journal of immunological methods
Published: January 13, 2012
Showing 1-12 of 12

Last Updated: 09/26/2026